Abeona Therapeutics Inc. (ABEO) vs Indaptus Therapeutics, Inc. (INDP)

A side-by-side comparison of Abeona Therapeutics Inc. and Indaptus Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ABEO vs INDP

growth of $100 · dividends reinvested · last 10y
ABEO -96.6% (-28.7%/yr)INDP -100.0% (-57.2%/yr)ABEO compounded faster over this window
Log scale — wide-divergence pair
0001101001kStart $10020182020202220242026$3$0
ABEO INDP

ABEO vs INDP: by the numbers

  • •ABEO is the larger company ($289M vs $286M market cap).
  • •Both run net losses; INDP's is the smaller (0.00% vs -246.42% net margin).

Metrics side by side

Valuation

MetricABEOINDP
P/S ratio11.33N/A
P/B ratio2.2625.14

Profitability

MetricABEOINDP
Gross margin73.68%0.00%
Operating margin-1536.91%0.00%
Net margin-246.42%0.00%
ROE-49.11%-135.62%
ROIC-49.76%-129.90%

Growth (annualized)

MetricABEOINDP
Revenue CAGR (5Y)-10.26%N/A
Total return CAGR (5Y)-26.46%-58.32%

Frequently asked

How have ABEO and INDP total returns compared?
Over the past 10 years, ABEO delivered -29.45% and INDP delivered -57.48% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.